Track #1 – Essential OEM Clinical Updates: Sessions 1,11,14
Silicosis, Vision Screening/Surveillance, Commercial Driving

Track #2 – Public Health Hot Topics: Sessions 2,3,10
E-cigarettes/Vaping, Marijuana Illegal Grow Sites, Wildfires

Track #3 – OEM Guidelines/Academic Topics: Sessions 4,5,6
TB, Bio-Psycho-Social, Law Enforcement Officers

Track #4 – COVID Updates: Sessions 7,8,9
Serology/Testing, Risk Communication, Epidemiology

Track #5 – OEM Leadership & Excellence: Sessions 12,13
Leading Through Crisis, Interacting with the Legal System, ACOEM and WOEMA Presidents’ Addresses


Plenary Session #1
Silicosis: Are We Doing Enough to Protect Workers?
Speaker: Robert Harrison, MD, UCSF 
Description: Silicosis is a preventable occupational disease that has been well-recognized for centuries yet has continued to occur in a number of occupations in the 21st century. In the past decade, severe silicosis has emerged among workers in the engineered ("artificial") stone industry across the globe, with recent outbreaks identified in the United States. 

Plenary Session #2:
Can We Escape the Vape? Morbidity and Mortality associated with E-cigarettes
Speaker: Neal Benowitz, MD, UCSF
Description: Discussion of the harms and risks of electronic cigarettes, and the public health debate as to the benefits and risks of e-cigarette use. Benefits involved reducing the harms from cigarette smoking and promoting smoking cessation. Harms may include direct safety concerns and the use of e-cigarettes by youths. Different types of e-cigarettes will be reviewed, as well as the e-cigarette vaping induced lung injury story.

Plenary Session #3:
Storm Clouds Gather: Unexpected Human Health and Environmental Illegal Hazards Related to Marijuana Growth Sites
Speaker: Lee Wugofski, MD, Federal Occupational Board, US Forest Service
Description: Since 2016, Federal Occupational Health has been engaged with the US Forest Service to monitor personnel involved in the identification and mitigation of illegal marijuana grows in remote areas of California. This presentation will cover the diverse nature of occupational and environmental hazards their Law Enforcement personnel face in the performance of duties in the Sierra Nevada mountain ranges. It will discuss the challenges associated with medical surveillance in such remote areas and present aggregate data on what has been learned to date, along with hypotheses to explain the findings.

Plenary Session #4:
Tuberculosis - That other Pulmonary Disease: How to Approach TB Screening and Treatment of Healthcare Personnel in 2020
Speakers: Wendy Thanassi, MD and Warner Hudson, MD
Description: In 2019, CDC published updates to TB screening in healthcare personnel which advocates for the elimination of annual TB screening and treatment of those diagnosed with latent TB with 12-dose (once weekly) isoniazid and rifapentine (3HP) or other preventive chemotherapy. A companion document was written to offer strategies for implementation and troubleshooting regarding the new guidelines. Since the Covid-19 worldwide pandemic, some similarities with the required exposure investigations and mass-testing programs have become evident.

Plenary Session #5:
Mechanisms Supporting Mindfulness Meditation Induced Pain Relief
Speaker: Fadel Zeidan, Ph.D., Department of Anesthesiology, UC San Diego
Description: Dr. Fadel Zeidan will describe the psychological, physiological, and neural processes that are involved in mindfulness meditation-based pain relief. He will also discuss how mindfulness is different from placebo and the potential clinical applications of mindfulness.

Plenary Session #6:
Law Enforcement Guidelines: Protecting Those Who Protect and Serve
Speaker: Mike Levine, MD, MPH; ACOEM
Description: ACOEM recently released a new chapter in its “Guidance for the Medical Evaluation of Law Enforcement Officers (LEOs)” on mental health issues. This session will provide an overview of the new chapter, provide practical examples for application of the guidelines in potentially difficult fitness-for-duty assessments, and will discuss the limitations of the guidelines in predicting episodes of the use of force by law enforcement officers. 

Plenary Session #7:
COVID-19 Testing: A Rational Approach 
Speaker: Kirstine Oh, MD, CellNetix Laboratories and Providence St. Joseph Health
Description: The presentation will focus on different methods of testing for SARS-CoV-2 and how to think about the clinical and analytic sensitivity, specificity, and positive and negative predictive values of results within the context of the natural history of the disease.

Plenary Session #8:
What Not To Say During a Pandemic: Do's and Don’ts of Risk Communication during COVID-19
Speaker: Mary McDaniel, DO, JD, MPH; Vice President and Medical Director, Intrinsik
Description: There are over five million confirmed COVID-19 cases in the U.S and nearly 200,000 people have died of virus-related illnesses in the U.S. How did we get here? This presentation is not a critique of the management of the response. This discussion focuses on risk communication as it pertains to understanding the views and perceptions of risk, and primarily, trust in the context of information about the pandemic. This presentation also covers some of the myths and realities of living with the pandemic and the science information that is presented to us on a daily basis.

Plenary Session #9:
Occupational Risks of COVID-19: Returning to a Safe Workplace
Speaker: Sara Luckhaupt, MD, Centers for Disease Control and Prevention
Description: In the current COVID-19 pandemic, new information is emerging about which industries and occupations pose a higher risk of exposing workers to the coronavirus. Dr. Luckhaupt will present information that will be useful for occupational medicine providers who must advise workers and employers about workplace safety and return-to-work.

Plenary Session #10:
What We Know Now: Public Health and Occupational Health Impacts of Wildfires 
Speaker: Kat Navarro, Ph.D.; NIOSH 
Description: This presentation will provide an overview of the wildland fire environment and current NIOSH research projects on wildland firefighter health.

Plenary Session #11:
The Eyes Have It: Occupational Vision Screening
Speaker: Kenji Saito, MD, JD,
Description: The occupational medicine clinician is routinely asked to perform vision screening for pre-employment and screening purposes, but selecting the proper test requires knowledge of its strengths and limitations. Furthermore, awareness of each test’s standardization and equipment is required to accurately assess results.

Plenary Session #12:
Leading Through Crisis: Keep Calm and Carry On
Speaker: Stephen Beeson, MD, Founder of the Clinician Experience Project at
Description: We are faced with unprecedented challenges in leading our healthcare teams. We are seeing strains on employers and care teams as patient flow, care delivery, and financial hardships grow with the persistence of COVID-19. In this session, we aim to outline the impact of COVID-19 and how that is influencing care delivery everywhere. We then look at how we take an insult like COVID-19, to fuel purpose, collaboration, friendship, and esprit de corps. We will challenge you to reflect on the leader and care team member you want to be in a crisis, and how to take actionable steps to make that happen.

Plenary Session #13:
Stating Your Case: How To Interact with the Legal System 
Speaker: Paul Baleria, JD, Partner, Lewis Brisbois
Description: A legal discussion that will provide an overview of the aspects of a medical malpractice case and offer practical information for a physician when subpoenaed for a deposition or contacted by the Medical Board.

Plenary Session #14:
Breaking News in Evaluating Commercial Drivers 
Speaker: Natalie Hartenbaum, MD, MPH, President and Chief Medical Officer of OccuMedix, Inc.
Description: This session will review recent updates with respect to commercial driver medical examination such as recent changes in medical standards, guidelines, or frequently asked questions. Information from recent Medical Review Board and Motor Carrier Safety Advisory Committee meetings will be presented.



ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Occupational and Environmental Medicine (ACOEM) and the Western Occupational & Environmental Medical Association (WOEMA). The ACOEM is accredited by the ACCME to provide continuing medical education to physicians.

AMA Credit Designation Statement
The American College of Occupational and Environmental Medicine designates this Live Activity for a maximum of 14.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

QME Credits
WOEMA is accredited by the Administrative Director of the California Division of Workers’ Compensation as a provider of Qualified Medical Evaluator (QME) continuing education (provider number 320). WOEMA takes responsibility for the content, quality, and scientific integrity of this CME activity.

The American Board of Occupational Health Nurses (ABOHN) American Nurse Credentialing Center (ANCC), American Academy of Nurse Practitioners (AANP), and American Academy of Physician Assistants (AAPA) may accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME or a recognized state medical society. Please check directly with your own licensing and/or certification agency for eligibility of these credits.